Clinical Trial Update: A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Phase 2 pilot study of IGF-1 in autism spectrum disorder has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Insulin-like Growth Factor-1 (insulin-like growth factor-1)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Autism Spectrum Disorder | Phase 2 | Status: TERMINATED | Results posted: 2024-02-08